[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=9077491ac095b7ba3090bba2af64f849f02f68131270318cfa0f156365d83b14",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733416860,
      "headline": "Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors",
      "id": 131877384,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=9077491ac095b7ba3090bba2af64f849f02f68131270318cfa0f156365d83b14"
    }
  },
  {
    "ts": null,
    "headline": "Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?",
    "summary": "The company is still suffering from the significant drop in sales of its coronavirus products and the less-than-impressive financial results it has produced during the past two years.  Pfizer has, unquestionably, made progress.  Many new approvals and acquisitions have expanded its lineup and pipeline.",
    "url": "https://finnhub.io/api/news?id=4965ba80cae77a7b2416beda9ac2c44b7ddcc78d5e5b83a22d0c808594c1e069",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733400900,
      "headline": "Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?",
      "id": 131791972,
      "image": "https://g.foolcdn.com/editorial/images/799291/scientist-altering-dna-genome-project.jpg",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "The company is still suffering from the significant drop in sales of its coronavirus products and the less-than-impressive financial results it has produced during the past two years.  Pfizer has, unquestionably, made progress.  Many new approvals and acquisitions have expanded its lineup and pipeline.",
      "url": "https://finnhub.io/api/news?id=4965ba80cae77a7b2416beda9ac2c44b7ddcc78d5e5b83a22d0c808594c1e069"
    }
  },
  {
    "ts": null,
    "headline": "3 of the Best Growth Stocks You Can Buy for Less than $100",
    "summary": "It's getting harder these days to find great growth stocks trading for less than $100 a share.  Just remember that doing so means buying in when there may still be some price volatility and risk involved.  If you're looking at investments priced at less than $100, then three of the best growth stocks to consider right now are CRISPR Therapeutics (NASDAQ: CRSP), Celsius (NASDAQ: CELH), and KB Home (NYSE: KBH).",
    "url": "https://finnhub.io/api/news?id=84de395493cb48ada1d699697675dfa1bebde8e790d0989c2c6dc160168ec43c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733394420,
      "headline": "3 of the Best Growth Stocks You Can Buy for Less than $100",
      "id": 131795111,
      "image": "https://g.foolcdn.com/editorial/images/799427/a-family-meeting-with-an-advisor.jpg",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "It's getting harder these days to find great growth stocks trading for less than $100 a share.  Just remember that doing so means buying in when there may still be some price volatility and risk involved.  If you're looking at investments priced at less than $100, then three of the best growth stocks to consider right now are CRISPR Therapeutics (NASDAQ: CRSP), Celsius (NASDAQ: CELH), and KB Home (NYSE: KBH).",
      "url": "https://finnhub.io/api/news?id=84de395493cb48ada1d699697675dfa1bebde8e790d0989c2c6dc160168ec43c"
    }
  }
]